Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23765234 | 0.95 | CNR1 (0.70) | CNR1CNR2 | |
| SCHEMBL23765170 | 0.94 | CNR1 (0.73) | CNR1CNR2 | |
| SCHEMBL23765173 | 0.85 | CNR2 (0.58) | CNR1CNR2 | |
| SCHEMBL22946426 | 0.80 | CNR2 (0.54) | CNR1CNR2 | |
| SCHEMBL29874512 | 0.80 | CNR2 (0.54) | CNR1CNR2 | |
| SCHEMBL23249706 | 0.80 | CNR2 (0.54) | CNR1CNR2 | |
| SCHEMBL23249707 | 0.80 | CNR2 (0.54) | CNR1CNR2 | |
| SCHEMBL23765328 | 0.80 | CNR2 (0.59) | CNR1CNR2 | |
| SCHEMBL23765260 | 0.79 | CNR2 (0.61) | CNR1CNR2 | |
| SCHEMBL25268322 | 0.79 | CNR2 (0.61) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| WO-2021163023-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. (US) | 2021-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | SLC25A20, CPT2, NDUFAB1 | CNR1 106/4885CNR2 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.